No effect of O-(beta-hydroxyethyl)-rutoside on red cell filterability in patients with acute myocardial infarction. 1990

L Waldenlind, and B L Edlund, and J Hulting, and F Lund

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004907 Erythrocyte Deformability Ability of ERYTHROCYTES to change shape as they pass through narrow spaces, such as the microvasculature. Erythrocyte Filterability,Deformability, Erythrocyte,Filterability, Erythrocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006896 Hydroxyethylrutoside Monohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders. 0-beta-Hydroxyethylrutoside,beta-Hydroxyethylrutoside,0 beta Hydroxyethylrutoside,beta Hydroxyethylrutoside
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

L Waldenlind, and B L Edlund, and J Hulting, and F Lund
January 1973, Bibliotheca anatomica,
L Waldenlind, and B L Edlund, and J Hulting, and F Lund
February 1977, AJR. American journal of roentgenology,
L Waldenlind, and B L Edlund, and J Hulting, and F Lund
January 1975, Bibliotheca anatomica,
L Waldenlind, and B L Edlund, and J Hulting, and F Lund
January 1979, Pharmacology,
L Waldenlind, and B L Edlund, and J Hulting, and F Lund
January 1981, Scandinavian journal of clinical and laboratory investigation. Supplementum,
L Waldenlind, and B L Edlund, and J Hulting, and F Lund
June 1973, Strahlentherapie,
L Waldenlind, and B L Edlund, and J Hulting, and F Lund
January 1987, VASA. Zeitschrift fur Gefasskrankheiten,
L Waldenlind, and B L Edlund, and J Hulting, and F Lund
October 1977, Xenobiotica; the fate of foreign compounds in biological systems,
L Waldenlind, and B L Edlund, and J Hulting, and F Lund
November 1970, Strahlentherapie,
L Waldenlind, and B L Edlund, and J Hulting, and F Lund
January 1981, VASA. Zeitschrift fur Gefasskrankheiten,
Copied contents to your clipboard!